European Patent Office

T 1212/97 (Immunoglobulin preparations/GENENTECH) du 14.05.2001

Identifiant européen de la jurisprudence
ECLI:EP:BA:2001:T121297.20010514
Date de la décision
14 mai 2001
Numéro de l'affaire
T 1212/97
Requête en révision de
-
Numéro de la demande
84302368.0
Classe de la CIB
C12N 15/13
Langue de la procédure
Anglais
Distribution
Distribuées aux présidents et aux membres des chambres de recours (B)
Téléchargement
Décision en anglais
Versions JO
Aucun lien JO trouvé
Autres décisions pour cet affaire
-
Résumés pour cette décision
-
Titre de la demande
Recombinant immunoglobulin preparations, methods for their preparation, DNA sequences, expression vectors and recombinant host cells therefor
Nom du demandeur
Genentech, Inc., et al
Nom de l'opposant
Bristol-Myers Company
Roche Diagnostics GmbH
Protein Design
Ortho Pharmaceutical Corp.
Celltech Limited
Chambre
3.3.04
Sommaire
-
Mots-clés
Oral presentation - state of the art (no)
Main request - claim 1 - sufficiency of disclosure (no)
Main request - claim 16 - novelty (no)
First auxiliary request - claim 1- sufficiency of disclosure (no)
Second auxiliary request - novelty (yes)
Inventive step (yes)
Adaptation of the description
Exergue
The information content made publicly available by a lecture cannot be put beyond reasonable doubt by any evidence of the lecturer alone, as the lecturer is in a quite different position to a member of the audience (see point 3 ff).

ORDER

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The Appellant's main and first auxiliary requests are refused.

3. The claim of the second auxiliary claim request meets the requirements of the European Patent Convention.

4. The matter is remitted to the first instance with the order to maintain the patent on the basis of the claim of the second auxiliary request submitted at oral proceedings on 26 May 2000, pages 1 to 23 of the description submitted as auxiliary request at oral proceedings on 14 May 2001, and the drawings as granted.

5. The request for re-imbursement of the appeal fee is refused.